<?xml version="1.0" encoding="UTF-8"?>
<ref id="pbio.3000124.ref005">
 <label>5</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Salzano</surname>
   <given-names>M.</given-names>
  </name>; 
  <name>
   <surname>Vazquez-Cedeira</surname>
   <given-names>M.</given-names>
  </name>; 
  <name>
   <surname>Sanz-Garcia</surname>
   <given-names>M.</given-names>
  </name>; 
  <name>
   <surname>Valbuena</surname>
   <given-names>A.</given-names>
  </name>; 
  <name>
   <surname>Blanco</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Fernandez</surname>
   <given-names>I.F.</given-names>
  </name>; 
  <name>
   <surname>Lazo</surname>
   <given-names>P.A.</given-names>
  </name>
  <article-title>Vaccinia-related kinase 1 (vrk1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage response</article-title>. 
  <source>
   <italic toggle="yes">Oncotarget</italic>
  </source>
  <year>2014</year>, 
  <volume>5</volume>, 
  <fpage>1770</fpage>â€“
  <lpage>1778</lpage>. 
  <pub-id pub-id-type="doi">10.18632/oncotarget.1678</pub-id>
  <?supplied-pmid 24731990?>
  <pub-id pub-id-type="pmid">24731990</pub-id>
 </mixed-citation>
</ref>
